Company American BriVision (Holding) Corporation OTC Markets
Equities
ABVC
US0247332069
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23/23/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01/21/01 |
Eugene Jiang
CHM | Chairman | 38 | 01/15/01 |
Chief Tech/Sci/R&D Officer | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10/22/10 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01/15/01 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23/17/23 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23/17/23 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23/17/23 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,878,376 | 8,003,326 ( 73.57 %) | 26,553 ( 0.2441 %) | 73.57 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+2.68% | 22.58B | |
-14.57% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |